mDHCR24 interference target spot sequence and application thereof
A technology of target sequence and RNA interference, which is applied in the field of molecular biology and biomedicine, can solve the problems of no uniform determination of the most effective target and great differences, and achieve the effect of inhibiting cytotoxicity and toxicity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0027] The acquisition of embodiment one siRNA
[0028] by Figure 1A The four mRNA sequences underlined in the shown mDHCR24 sequence, namely: 5-GCACAGGCATCGAGTCATC-3, 5-GCACGGGTTCCAAATGTTA-3, 5-GCGCCTGGGTGGTGTTCAA-3, and 5-ACTCAGACCTGTTCTATGC-3 are the RNA interference target sequences of mDHCR24, corresponding to siRNAs were designed for each RNA interference target sequence and obtained by chemical synthesis from Dharmacon to obtain four siRNAs.
Embodiment 2
[0029] Example 2 Combined application of siRNAs complex and liposome transfection reagent DharmaFECT 1
[0030] In this example, the liposome transfection reagent used DharmaFECT 1, a special reagent for RNA interference from Dhamacon, and siGENOME Control siRNA from Dharmacon was used as a control for RNA interference. The effectiveness of RNAi interference was verified by semi-quantitative PCR, and its cytotoxicity The detection adopts differential microscope observation and cell counting method to evaluate.
[0031] Using the four siRNAs obtained in Example 1, the four siRNAs were combined to form a siRNAs complex and used in combination with liposome transfection reagent DharmaFECT 1.
[0032] (1) The toxicity of liposome transfection reagent DharmaFECT 1 to cells.
[0033] N2A cells were trypsinized according to 2.5x10 4 / cm 2 The density was planted in a 12-well plate, cultured in medium without antibiotics, and liposome transfection was performed 24 hours later. The...
Embodiment 3
[0045] Example 3 Combined application of siRNAs complex and liposome transfection reagent siPORT Lipid
[0046] Using the four siRNAs obtained in Example 1, the four siRNAs were combined to form a siRNAs complex and used in combination with the liposome transfection reagent siPORT Lipid.
[0047] In this example, in order to prove the versatility of siDHCR4 in reducing the cytotoxicity of liposome transfection reagents, the siPORT Lipid produced by Ambion was used as the liposome transfection reagent, and the siRNA targeting Ambio's cell caveolin1 was used (ID53643) was used to test the target siRNA, and was transfected according to the transfection conditions of Ambio Company. The effectiveness of RNAi interference was verified by semi-quantitative PCR method, and its cytotoxicity was detected by differential microscope observation and cell counting method.
[0048] N2A cells were trypsinized according to 2.5x10 4 / cm 2 The density was planted in a 6-well plate, cultured w...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com